Pharmaniaga Berhad (KLSE:PHARMA)

Market Cap	1.74B +317.3%
Revenue (ttm)	4.05B +5.2%
Net Income	50.40M -62.9%
EPS	0.05 -89.1%
Shares Out	1.31B
PE Ratio	25.85
Forward PE	7.25
Dividend	0.03 (1.88%)
Ex-Dividend Date	Jun 5, 2026

Volume	4,351,300
Open	1.290
Previous Close	1.290
Day's Range	1.270 - 1.330
52-Week Range	0.650 - 1.700
Beta	0.77
Analysts	Buy
Price Target	0.69 (-48.12%)
Earnings Date	Aug 19, 2026

About Pharmaniaga Berhad

Pharmaniaga Berhad, an investment holding company, operates as an integrated healthcare service provider in Malaysia, Indonesia, and internationally. The company operates through Logistics and Distribution, Manufacturing, and Indonesia segments. It is involved in manufacturing, distribution, and marketing of pharmaceutical and medical products, such as generic drugs and over-the-counter medicines; supply and installation of medical and hospital equipment; and research and development of pharmaceutical products. The company also produces and dis...

• Industry: Drug Stores and Proprietary Stores
• Founded: 1994
• Employees: 3,502
• Stock Exchange: Bursa Malaysia
• Ticker Symbol: PHARMA

Financial Performance

In 2025, Pharmaniaga Berhad's revenue was 3.93 billion, an increase of 4.48% compared to the previous year's 3.76 billion. Earnings were 48.51 million, a decrease of -63.20%.

Analyst Summary

According to 3 analysts, the average rating for PHARMA stock is "Buy." The 12-month stock price target is RM 0.69, which is a decrease of -48.12% from the latest price.

Price Target

RM 0.69

(-48.12% downside)

Analyst Consensus: Buy